Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2012 by Hadassah Medical Organization.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
Kerem Eithan, Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00889434
First received: April 20, 2009
Last updated: November 11, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)